Ethereum appears to be gaining momentum over Bitcoin, and that might lead to a shift in the market dynamics. A last dip is expected before the next leg up.Ethereum appears to be gaining momentum over Bitcoin, and that might lead to a shift in the market dynamics. A last dip is expected before the next leg up.

Ethereum Gains 2.4% Against Bitcoin as Altcoins Eye 200–500% Rally: Michaël van de Poppe

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
ethereum60-1

Ethereum appears to be gaining momentum over Bitcoin, and that might lead to the shift in the market dynamics. According to crypto analyst Michael van de Poppe, ETH is beginning to bottom at the 0.03250 level, the level before likely initiating a trend change.  

In the past 24 hours, Ethereum made a 2.4% gain to the level of $4,680, surpassing the minimal 0.24% gain made by Bitcoin to the price level of $124,200. ETH’s improved performance has raised expectations for altcoins, which typically perform well when Ethereum leads the market.  

Ethereum Gains Ground Against Bitcoin 

ETH/BTC is trading at approximately 0.03770, and the daily 21-EMA is at 0.03738, a point that provides short-term support. A sound basis has also accumulated around 0.0355, and this makes the traders feel more confident that the downside effect of ETH may not be much in the near future.  

Van de Poppe indicates that an overcoming of important resistance levels may indicate a permanent turnaround. The primary resistance is close to 0.03687; should ETH surpass this, it might result in extended continuity of the era of dominance of ETH.  

The analyst indicated that the turn of ETH against Bitcoin frequently provides the altcoin market with momentum. In cases of ETH increases, capital tends to move to smaller-cap coins, driving large price increases throughout the altcoins.

Altcoins Begin to Outperform as Market Rotation Strengthens

Some of the large altcoins, like TRX, are currently performing better than Ethereum and Bitcoin. This is an indication that traders are now seeking risky investments.

According to Van de Poppe, this change may accelerate in the coming weeks, and altcoins may start going back 200-500 percent in case the market continues being positive. The changes occur frequently in the crypto world, often after Bitcoin is stable and Ethereum takes the lead once more.

This does not imply that the altcoins will remain elevated in the long run; however, it is initially encouraging that there is increased confidence in the entire market of digital assets.

Key Levels to Watch for Ethereum and the Market Ahead

The short-term outlook of Ethereum is to remain by the 0.03738 moving average and hold onto the 0.0355 level of support. In case it does, it can be taken as a bigger recovery against Bitcoin.

Currently, the market maintains an optimistic outlook. The increase in price of Ethereum has already increased the trading of altcoins, and assuming the trend continues, more volatility in the next few weeks may be witnessed in the crypto market, and possibly more upside momentum.

Market Opportunity
4 Logo
4 Price(4)
$0.008042
$0.008042$0.008042
-1.74%
USD
4 (4) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09